Multiple Sclerosis (MS) Does Not Worsen Following Pregnancy

Highlights:

Post pregnancy period does not increase the risk of relapse of multiple sclerosis or cause a deterioration in the condition as currently believed according to this latest study
Most patients have the relapsing and remitting form of the disease where the symptoms settle down for a period and then suddenly flare up. The condition is common in women in the reproductive age
Women can safely undergo pregnancy, breastfeed their babies and resume treatment after delivery without increased risk of worsening of symptoms and deterioration

Women diagnosed with multiple sclerosis need not worry about the risk of worsening of the condition or a flare-up immediately after pregnancy, according to the findings of a recent study at Kaiser Permanente Southern California in Pasadena.

The findings of the study will be presented at the American Academy of Neurology's 71st Annual Meeting in Philadelphia.

Listen to this article

0:00/0:00

Possible Mechanism for Protective Effect of Testosterone in Multiple Sclerosis Uncovered
The protective mechanism of testosterone in multiple sclerosis has been suggested to be due to the production of a molecule called interleukin-33 (IL-33).

‘Multiple sclerosis (MS) is quite common in women in their reproductive age. However, this study suggests that women can safely undergo pregnancies, breastfeed and restart their treatment without worrying about the risk of relapse post delivery.’
Read More..

Tweet it Now

Annette Langer-Gould, MD, Ph.D., of Kaiser Permanente, the study author said: "These results are exciting, as MS is more common among women of childbearing age than in any other group. This shows us that women with MS today can have children, breastfeed and resume their treatment without experiencing an increased risk of relapses during the postpartum period."

Does Childbirth Increase Risk of Multiple Sclerosis Relapse

Until now it was believed that multiple sclerosis symptoms deteriorate after childbirth. The study team hoped to determine if this information that was put forth 20 years ago is still valid in the modern scenario where disease-modifying treatments have become available and MRI scans can diagnose multiple sclerosis in the very early stages before it can progress.

The study team went through all patient records from Kaiser Permanente Southern and Northern California databases and found 375 women with MS accounting for 466 pregnancies from 2008 to 2016.
They surveyed the women for more information about treatment history, pregnancy details, breastfeeding and episodes of remission and relapse
Of the 375 women, 38 percent reported not receiving any treatment for MS in the year prior to becoming pregnant.
A total of 15 percent just had the clinically isolated syndrome, which is the first occurrence of MS symptoms when they became pregnant
A small proportion of the women (8%) had a relapse during pregnancy.
Following delivery, 26 percent of the women had a flare-up, 87 percent breastfed their babies of which 35 percent breastfed exclusively.
41 percent of participants resumed taking their disease-modifying treatments after delivery
Before pregnancy, the yearly relapse rate was 0.39, which fell to 0.07 to 0.14 during pregnancy.
After birth, the symptoms did not worsen more, showing a rate in the first three months after the birth of 0.27, slightly less than pre-pregnancy relapse rates
By four to six months after delivery, the relapse rate had returned to the pre-pregnancy baseline level of 0.37

The results remained the same even after the scientists adjusted for other influencing factors that could affect the relapse rate, including the severity of the symptoms before pregnancy.

Interestingly, breastfeeding the baby appeared to be beneficial in reducing the risk of Multiple Sclerosis relapse.

Women who breastfed their babies on their milk exclusively for the first two months had a 40% lower risk of relapse compared to women who did not breastfeed.
Of the 167 women who breastfed exclusively, 67 resumed disease-modifying agents while they were breastfeeding
Restarting moderately effective disease-modifying agents such as interferon-betas and glatiramer acetate did not influence the rate of relapse
Women who gave formula in addition to breast milk within two months after delivery appeared to have a similar risk of relapse as women who never breastfed

The findings of the study indicate that childbirth does not increase the risk of relapse of multiple sclerosis. According to the author, the lower rates of relapse following childbirth in this study could be due to the inclusion of women who just had one isolated episode as well as a high proportion of women who exclusively breastfed.

Future Plans

Further studies need to be conducted to further analyze the subgroup of women with severe relapses related to cessation of treatment such as natalizumab or fingolimod that they were taking prior to pregnancy.

Summary

The period immediately after delivery in women with multiple sclerosis does not increase the risk of relapse of the condition. Women with MS can have babies, breastfeed them and restart their medications after childbirth.

Reference :

Good news for women with ms: Disease may not worsen after pregnancy after all - (https://www.aan.com/PressRoom/Home/PressRelease/2703)

Source: Medindia

Can Breastfeeding Reduce The Risk of Developing Multiple Sclerosis?
Mothers, especially those who breastfeed for at least 15 months or more, were found to be less likely to develop multiple sclerosis in later years of life.

Cite this Article

<< New Smartphone App Can Help Monitor Blood Pressure Remotely

Hookah Smoke Can Affect Your Heart Health: Here's How >>

Pregnant Women With Multiple Sclerosis Less Likely to Suffer Complications
A new study has revealed that pregnant women with multiple sclerosis are at a modest risk of suffering complications or having caesarean deliveries.

Multiple Sclerosis - Famous Personalities
Multiple sclerosis affects more females than males and it is estimated that there are over a million people around the world.